BOSTON — GSK has been creating vaccines underneath one company guise or one other for 140 years, ever since a rural Pennsylvania physician began pumping smallpox pictures out of a transformed rooster home in 1882, however the firm could also be most recognized as we speak for the vaccine it didn’t construct.
The British pharma elected to not develop its personal Covid shot. It missed out on the celebrity and fortune and Pfizer-hyping TikToks that got here with curbing a once-in-a-century pandemic. Within the course of, it additionally confronted its personal inner dissension and an exodus of prime expertise.
It’s Phil Dormitzer’s job to vary that. A key determine in Pfizer’s Covid vaccine effort, Dormitzer jumped to GSK in December 2021 to be world head of R&D for a division that developed greater than 20 licensed vaccines, however gave the impression to be slipping behind new rivals with newer applied sciences.
Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!
GET STARTED